H. Rachelle Wallage
Research Subjects
H. Rachelle Wallage has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Marie Elliot
The Centre of Forensic Sciences , 25 Morton Shulman Ave, Toronto, ON M3M 0B1
2 shared publicationsInger M. Bugyra
Centre of Forensic Sciences, 25 Morton Shulman Avenue, Toronto, ON, Canada M3M 0B1
1 shared publicationJames H. Watterson
Laurentian University, Department of Forensic Science , 935 Ramsey Lake Rd., Sudbury, Ontario, P3L 1C6 Canada
1 shared publicationJames W Rajotte
Toxicology Section, Centre of Forensic Sciences , Suite 500, 70 Foster Drive, Sault Ste. Marie, ON P6A 6V3, Canada
1 shared publication
Latest Publications
- 25 October 2024
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 49 (2) , 129-133
Postmortem diphenhydramine blood concentrations in children
Diphenhydramine has been available for decades in non-prescription formulations for the treatment of allergic reactions, insomnia, and symptomology associated with colds. In addition, dimenhydrinate, a precursor to diphenhydramine, is available in preparations for the treatment of nausea and vomiting. Diphenhydramine and other first-generation antihistamines are being replaced by second- and third-generation antihistamines, which are associated with fewer side effects, notably the lack of drowsiness; however, there are still a variety of therapeutic uses that have persisted in both adults and children. In this study, postmortem blood concentrations of diphenhydramine were determined, by liquid chromatography–tandem mass spectrometry, in seven children with concentrations ranging from 0.051 to 2.6 mg/l. The cause of death in two cases was attributed, at least in part, to diphenhydramine toxicity, while diphenhydramine detection in five cases was considered incidental to the cause of death.
- 25 October 2024
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 49 (2) , 129-133
Postmortem diphenhydramine blood concentrations in children
Diphenhydramine has been available for decades in non-prescription formulations for the treatment of allergic reactions, insomnia, and symptomology associated with colds. In addition, dimenhydrinate, a precursor to diphenhydramine, is available in preparations for the treatment of nausea and vomiting. Diphenhydramine and other first-generation antihistamines are being replaced by second- and third-generation antihistamines, which are associated with fewer side effects, notably the lack of drowsiness; however, there are still a variety of therapeutic uses that have persisted in both adults and children. In this study, postmortem blood concentrations of diphenhydramine were determined, by liquid chromatography–tandem mass spectrometry, in seven children with concentrations ranging from 0.051 to 2.6 mg/l. The cause of death in two cases was attributed, at least in part, to diphenhydramine toxicity, while diphenhydramine detection in five cases was considered incidental to the cause of death.
- Open Access
- 18 June 2022
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 46 (8) , 860-865
Carfentanil Blood Concentrations in Impaired Driving Investigations in Ontario, Canada
Carfentanil is a potent opioid with no medical use in humans; it presents a serious threat to public health and road safety due to its presence in the illicit drug supply, the potency of the drug and instances of use prior to the operation of a motor vehicle. The identification and quantitation of carfentanil using liquid chromatography with tandem mass spectrometry was performed in blood samples obtained through impaired driving-related investigations from 2017 to 2019. In a series of 66 cases submitted to the Centre of Forensic Sciences in Ontario, Canada, blood concentrations of carfentanil ranged from <0.04 to 2.1 ng/mL in the population studied. Driving behaviors frequently came to the attention of concerned citizens, decreased levels of consciousness were commonly reported and a variety of medical interventions were required, in some cases, to preserve life due to apparent opioid toxicity.
- 18 June 2022
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 46 (8) , 860-865
Open AccessCarfentanil Blood Concentrations in Impaired Driving Investigations in Ontario, Canada
Carfentanil is a potent opioid with no medical use in humans; it presents a serious threat to public health and road safety due to its presence in the illicit drug supply, the potency of the drug and instances of use prior to the operation of a motor vehicle. The identification and quantitation of carfentanil using liquid chromatography with tandem mass spectrometry was performed in blood samples obtained through impaired driving-related investigations from 2017 to 2019. In a series of 66 cases submitted to the Centre of Forensic Sciences in Ontario, Canada, blood concentrations of carfentanil ranged from <0.04 to 2.1 ng/mL in the population studied. Driving behaviors frequently came to the attention of concerned citizens, decreased levels of consciousness were commonly reported and a variety of medical interventions were required, in some cases, to preserve life due to apparent opioid toxicity.
- 22 May 2017
- Published by Taylor & Francis in Canadian Society of Forensic Science Journal
- Vol. 50 (4) , 157-163
“Interferent Detect” on the Intoxilyzer® 8000C in an individual with an elevated blood acetone concentration due to ketoacidosis
A 72-year-old male was arrested for impaired driving. He had a history of chronic alcohol 1 1. Alcohol and ethanol are used interchangeably throughout the document. View all notes consumption and limited food intake on the day of his arrest. The Intoxilyzer® 8000C provided the following communication messages during testing: “Interferent Detect”, “Invalid Sample” and then an additional “Interferent Detect.” This information from the Intoxilyzer® 8000C prompted a medical investigation. The individual was taken to the hospital where ketoacidosis was part of the medical diagnosis. Blood samples were collected and analyzed at two hospital laboratories and the Centre of Forensic Sciences. The results from the hospital analyses were serum ethanol concentrations of 172 and 161 mg/100 mL and an acetone concentration of 18 mg/100 mL; the results from the forensic analyses were blood ethanol, acetone, isopropanol and beta-hydroxybutyrate concentrations of 139 mg/100 mL, 21 mg/100 mL, <5 mg/100 mL and 468 mg/L, respectively.
- 22 May 2017
- Published by Taylor & Francis in Canadian Society of Forensic Science Journal
- Vol. 50 (4) , 157-163
“Interferent Detect” on the Intoxilyzer® 8000C in an individual with an elevated blood acetone concentration due to ketoacidosis
A 72-year-old male was arrested for impaired driving. He had a history of chronic alcohol 1 1. Alcohol and ethanol are used interchangeably throughout the document. View all notes consumption and limited food intake on the day of his arrest. The Intoxilyzer® 8000C provided the following communication messages during testing: “Interferent Detect”, “Invalid Sample” and then an additional “Interferent Detect.” This information from the Intoxilyzer® 8000C prompted a medical investigation. The individual was taken to the hospital where ketoacidosis was part of the medical diagnosis. Blood samples were collected and analyzed at two hospital laboratories and the Centre of Forensic Sciences. The results from the hospital analyses were serum ethanol concentrations of 172 and 161 mg/100 mL and an acetone concentration of 18 mg/100 mL; the results from the forensic analyses were blood ethanol, acetone, isopropanol and beta-hydroxybutyrate concentrations of 139 mg/100 mL, 21 mg/100 mL, <5 mg/100 mL and 468 mg/L, respectively.
- Open Access
- 1 April 2008
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 32 (3) , 241-247
Formic Acid and Methanol Concentrations in Death Investigations
Methanol ingestion results in the formation of formic acid, a toxic metabolite that can cause metabolic acidosis. Methanol toxicity is therefore dependent on the amount of methanol ingested, the nature of treatment received, elapsed time since ingestion, and the accumulation of formic acid. Both methanol and formic acid concentrations are determined at this laboratory using headspace gas chromatography. An examination of 12 fatalities attributed to methanol poisoning is presented. Six individuals were found deceased, and their postmortem methanol and formic acid concentrations ranged from 84 to 543 mg/dL and 64 to 110 mg/dL, respectively. In the other six individuals, hospital treatment such as bicarbonate, ethanol infusion, and hemodialysis was administered. Antemortem methanol and formic acid concentrations ranged from 68 to 427 mg/dl, and 37 to 91 mg/dL, respectively, whereas corresponding postmortem methanol and formic acid levels ranged from undetectable to 49 mg/dL and undetectable to 48 mg/dL, respectively. Hospital treatment of formic acid toxicity resulted in significantly reduced postmortem methanol and formic acid concentrations. Furthermore, the toxicological relevance of nine methanol-positive cases where postmortem methanol concentrations ranged from 3 to 142 mg/dL, with corresponding formic acid levels of less than 10 mg/dr, is discussed.
- 1 April 2008
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 32 (3) , 241-247
Open AccessFormic Acid and Methanol Concentrations in Death Investigations
Methanol ingestion results in the formation of formic acid, a toxic metabolite that can cause metabolic acidosis. Methanol toxicity is therefore dependent on the amount of methanol ingested, the nature of treatment received, elapsed time since ingestion, and the accumulation of formic acid. Both methanol and formic acid concentrations are determined at this laboratory using headspace gas chromatography. An examination of 12 fatalities attributed to methanol poisoning is presented. Six individuals were found deceased, and their postmortem methanol and formic acid concentrations ranged from 84 to 543 mg/dL and 64 to 110 mg/dL, respectively. In the other six individuals, hospital treatment such as bicarbonate, ethanol infusion, and hemodialysis was administered. Antemortem methanol and formic acid concentrations ranged from 68 to 427 mg/dl, and 37 to 91 mg/dL, respectively, whereas corresponding postmortem methanol and formic acid levels ranged from undetectable to 49 mg/dL and undetectable to 48 mg/dL, respectively. Hospital treatment of formic acid toxicity resulted in significantly reduced postmortem methanol and formic acid concentrations. Furthermore, the toxicological relevance of nine methanol-positive cases where postmortem methanol concentrations ranged from 3 to 142 mg/dL, with corresponding formic acid levels of less than 10 mg/dr, is discussed.